THRomboprophylaxis in Individuals Undergoing Superficial endoVEnous Treatment (THRIVE)

Exclusion Criteria

• •Clinical indication for therapeutic anticoagulation e.g., atrial fibrillation
• •Previous personal or first-degree relative history of VTE
• •Thrombophilia
• •Female patients of childbearing potential who have a positive pregnancy test
• •A history of allergy to heparins or direct oral anticoagulants
• •A history of heparin-induced thrombocytopenia
• •Inherited and acquired bleeding disorders
• •Evidence of active bleeding
• •Concomitant major health problems such as active cancer and chronic renal and/or liver impairment
• •Known thrombocytopenia (platelets known to be less than 50 x 109
• •/l)
• •Surgery or major trauma in the previous 90 days
• •Recent ischemic stroke in the previous 90 days
• •Inability to provide consent